Agency Information Collection Activities: Proposed Collection; Comments Requested, 11968 [E9-6054]

Download as PDF 11968 Federal Register / Vol. 74, No. 53 / Friday, March 20, 2009 / Notices By order of the Commission. Issued: March 16, 2009. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E9–6129 Filed 3–19–09; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0037] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 30-day notice of information collection under review. Prescription Drug Monitoring Program Questionnaire The Department of Justice (DOJ), Drug Enforcement Administration (DEA) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 74, Number 8, page 1709, on, January 13, 2009, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until April 20, 2009. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/ or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to (202) 395–5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, VerDate Nov<24>2008 17:07 Mar 19, 2009 Jkt 217001 including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of Information Collection 1117–0037: (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Prescription Drug Monitoring Program Questionnaire. (3) Agency Form Number, if Any, and the Applicable Component of the Department of Justice Sponsoring the Collection: Form Number: None. Office of Diversion Control, Drug Enforcement Administration, Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: States. Other: None. Abstract: This questionnaire permits the Drug Enforcement Administration to compile and evaluate information regarding the design, implementation and operation of State prescription monitoring programs. Such information allows DEA to assist states in the development of new programs designed to enhance the ability of both DEA and State authorities to prevent, detect, and investigate the diversion and abuse of controlled substances. (5) An Estimate of the Total Number of Respondents and the Amount of Time Estimated for an Average Respondent to Respond: It is estimated that 51 persons complete the Prescription Monitoring Program Questionnaire electronically, at 5 hours per form, for an annual burden of 255 hours. (6) An Estimate of the Total Public Burden (in Hours) Associated With the Collection: It is estimated that there are 255 burden hours associated with this collection. If additional information is required contact: Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW., Washington, DC 20530. PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Dated: March 11, 2009. Lynn Bryant, Department Clearance Officer, United States Department of Justice. [FR Doc. E9–6054 Filed 3–19–09; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE National Institute of Corrections Solicitation for a Cooperative Agreement—Direct Supervision: Curriculum Development AGENCY: National Institute of Corrections, Department of Justice. ACTION: Solicitation for a cooperative agreement. SUMMARY: The National Institute of Corrections, Jails Division, is seeking applications for the development of two training-program curricula: one that focuses on the role of the housing-unit officer and shift supervisor in a direct supervision jail and another that focuses on the role of the administrator in a direct supervision jail. The project will be for an eighteen-month period, and will be carried out in conjunction with the NIC Jails Division. NIC Jails Division staff will direct the project and will participate in curriculum design, lesson plan development, and the creation of related training materials. DATES: Applications must be received by 4 p.m. (EDT) on Friday, April 10, 2009. ADDRESSES: Mailed applications must be sent to: Director, National Institute of Corrections, 320 First Street, NW., Room 5007, Washington, DC 20534. Applicants are encouraged to use Federal Express, UPS, or a similar service to ensure delivery by the due date, as mail at NIC is sometimes delayed due to security screening. Applicants who wish to hand-deliver their applications should bring them to 500 First Street, NW., Washington, DC 20534 and dial (202) 307–3106, ext. 0 at the front desk for pickup. Faxed or e-mailed applications will not be accepted. FOR FURTHER INFORMATION CONTACT: A copy of this announcement and the required application forms can be downloaded from the NIC Web page at https://www.nicic.gov. All technical or programmatic questions concerning this announcement should be directed to Robbye Braxton-Mintz, Correctional Program Specialist, National Institute of Corrections. She can reached by calling 1–800–995–6423 ext. 4–4562 or by email at rbraxtonmintz@bop.gov. E:\FR\FM\20MRN1.SGM 20MRN1

Agencies

[Federal Register Volume 74, Number 53 (Friday, March 20, 2009)]
[Notices]
[Page 11968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-6054]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0037]


Agency Information Collection Activities: Proposed Collection; 
Comments Requested

ACTION: 30-day notice of information collection under review.

-----------------------------------------------------------------------

Prescription Drug Monitoring Program Questionnaire

    The Department of Justice (DOJ), Drug Enforcement Administration 
(DEA) will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection is published to obtain comments from the public 
and affected agencies. This proposed information collection was 
previously published in the Federal Register Volume 74, Number 8, page 
1709, on, January 13, 2009, allowing for a 60 day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until April 20, 2009. This process is conducted in 
accordance with 5 CFR 1320.10. Written comments and/or suggestions 
regarding the items contained in this notice, especially the estimated 
public burden and associated response time, should be directed to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503. Additionally, comments may be submitted to OMB via facsimile to 
(202) 395-5806.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agencies estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.
    Overview of Information Collection 1117-0037:
    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Prescription Drug Monitoring 
Program Questionnaire.
    (3) Agency Form Number, if Any, and the Applicable Component of the 
Department of Justice Sponsoring the Collection: Form Number: None. 
Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: States.
    Other: None.
    Abstract: This questionnaire permits the Drug Enforcement 
Administration to compile and evaluate information regarding the 
design, implementation and operation of State prescription monitoring 
programs. Such information allows DEA to assist states in the 
development of new programs designed to enhance the ability of both DEA 
and State authorities to prevent, detect, and investigate the diversion 
and abuse of controlled substances.
    (5) An Estimate of the Total Number of Respondents and the Amount 
of Time Estimated for an Average Respondent to Respond: It is estimated 
that 51 persons complete the Prescription Monitoring Program 
Questionnaire electronically, at 5 hours per form, for an annual burden 
of 255 hours.
    (6) An Estimate of the Total Public Burden (in Hours) Associated 
With the Collection: It is estimated that there are 255 burden hours 
associated with this collection.
    If additional information is required contact: Lynn Bryant, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street NW., Washington, DC 20530.

    Dated: March 11, 2009.
Lynn Bryant,
Department Clearance Officer, United States Department of Justice.
[FR Doc. E9-6054 Filed 3-19-09; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.